保加利亚肝功能异常门诊患者丁型肝炎病毒血清阳性率。

IF 1.5 4区医学 Q4 MICROBIOLOGY

New Microbiologica Pub Date : 2024-07-01

Denitsa Tsaneva-Damyanova

{"title":"保加利亚肝功能异常门诊患者丁型肝炎病毒血清阳性率。","authors":"Denitsa Tsaneva-Damyanova","doi":"","DOIUrl":null,"url":null,"abstract":"The aim of this research was to define the prevalence of antibodies against hepatitis D virus (anti-HDV Ab) in a group of 26 outpatients with liver dysfunction in northeastern Bulgaria. Serum samples were obtained from April 2022 to December 2023 in the \"Status\" Medical Diagnostic Laboratory, Varna, Bulgaria. We found seroprevalence of anti-HDV Ab in 15.4% (CI: 4.3-34.8%) of the target population. Age and gender had no significant role in HDV seropositivity.","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"47 2","pages":"180-182"},"PeriodicalIF":1.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seroprevalence of hepatitis D virus in Bulgarian outpatients with history of liver dysfunction.\",\"authors\":\"Denitsa Tsaneva-Damyanova\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The aim of this research was to define the prevalence of antibodies against hepatitis D virus (anti-HDV Ab) in a group of 26 outpatients with liver dysfunction in northeastern Bulgaria. Serum samples were obtained from April 2022 to December 2023 in the \\\"Status\\\" Medical Diagnostic Laboratory, Varna, Bulgaria. We found seroprevalence of anti-HDV Ab in 15.4% (CI: 4.3-34.8%) of the target population. Age and gender had no significant role in HDV seropositivity.\",\"PeriodicalId\":54723,\"journal\":{\"name\":\"New Microbiologica\",\"volume\":\"47 2\",\"pages\":\"180-182\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New Microbiologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Microbiologica","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本研究旨在确定保加利亚东北部 26 名肝功能异常门诊患者体内 D 型肝炎病毒抗体（抗 D 型肝炎病毒抗体）的流行率。血清样本于 2022 年 4 月至 2023 年 12 月在保加利亚瓦尔纳的 "Status "医学诊断实验室采集。我们发现，在目标人群中，抗高密度脂蛋白胆固醇病毒抗体的血清流行率为 15.4%（CI：4.3-34.8%）。年龄和性别对 HDV 血清阳性率没有明显影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Seroprevalence of hepatitis D virus in Bulgarian outpatients with history of liver dysfunction.

The aim of this research was to define the prevalence of antibodies against hepatitis D virus (anti-HDV Ab) in a group of 26 outpatients with liver dysfunction in northeastern Bulgaria. Serum samples were obtained from April 2022 to December 2023 in the "Status" Medical Diagnostic Laboratory, Varna, Bulgaria. We found seroprevalence of anti-HDV Ab in 15.4% (CI: 4.3-34.8%) of the target population. Age and gender had no significant role in HDV seropositivity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

New Microbiologica 生物-微生物学

CiteScore

2.20

自引率

5.60%

发文量

审稿时长

6-12 weeks

期刊介绍： The publication, diffusion and furtherance of research and study on all aspects of basic and clinical Microbiology and related fields are the chief aims of the journal.